Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.49 |
| ▸ | LPL | P06858 | 12/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL429978 | 0.87 | LIPG (0.53) | LIPGLPLCYP1A2IRAK4ALDH1A1 | |
| SCHEMBL17728193 | 0.84 | LIPG (0.49) | LIPGLPLIRAK4CSF1REGFR | |
| SCHEMBL6126262 | 0.83 | LPL (0.53) | LIPGLPLIRAK4CSF1R | |
| SCHEMBL5782260 | 0.82 | LPL (0.50) | LIPGLPLCYP1A2IRAK4ALDH1A1 | |
| SCHEMBL2261034 | 0.82 | LPL (0.58) | LIPGLPLCYP1A2IRAK4ALDH1A1 | |
| SCHEMBL25668979 | 0.81 | LPL (0.50) | LIPGLPLIRAK4EGFR | |
| SCHEMBL1627177 | 0.81 | LPL (0.51) | LIPGLPLIRAK4CSF1R | |
| SCHEMBL25622442 | 0.81 | LPL (0.56) | LIPGLPLCYP1A2IRAK4ALDH1A1 | |
| SCHEMBL5782969 | 0.80 | CSF1R (0.47) | LIPGLPLIRAK4ALDH1A1CSF1R | |
| Ammonia Solution, Strong SCHEMBL28683674 | 0.79 | LPL (0.44) | LIPGLPLCYP1A2IRAK4CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| EP-2045231-A1 | Binaphthyl compound and organic light emitting element using the same | Canon Kabushiki Kaisha (JP) | 2009-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | ALPL, MT-ND4L, LAGE3 | LIPG 2208/4885LPL 1254/4885CYP1A2 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.